Applied Finance Capital Management LLC Sells 8,337 Shares of Humana Inc. (NYSE:HUM)

Applied Finance Capital Management LLC reduced its holdings in shares of Humana Inc. (NYSE:HUM) by 74.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,895 shares of the insurance provider’s stock after selling 8,337 shares during the quarter. Applied Finance Capital Management LLC’s holdings in Humana were worth $734,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of HUM. Pinnacle Wealth Management Advisory Group LLC lifted its stake in shares of Humana by 3.6% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after acquiring an additional 37 shares during the last quarter. Atlas Brown Inc. raised its position in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after purchasing an additional 38 shares during the last quarter. Mather Group LLC. boosted its stake in shares of Humana by 21.0% during the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after purchasing an additional 41 shares in the last quarter. Capital Advisors Ltd. LLC grew its holdings in shares of Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 43 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. increased its stake in shares of Humana by 4.7% in the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock valued at $245,000 after buying an additional 43 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Performance

Shares of Humana stock opened at $280.63 on Wednesday. The business has a 50-day simple moving average of $266.00 and a 200 day simple moving average of $271.01. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market capitalization of $33.87 billion, a price-to-earnings ratio of 28.20, a PEG ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Royal Bank of Canada reiterated an “outperform” rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Truist Financial raised their target price on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. JPMorgan Chase & Co. reduced their price target on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Finally, Piper Sandler raised their price objective on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Seventeen analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, Humana presently has an average rating of “Hold” and a consensus target price of $280.17.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.